Faradarmani Consciousness Field Suppresses Alzheimer’s Disease Development in both in vitro and in vivo Models of the Disease

Alzheimer’s disease is one of the most common causes of memory loss and imposes a substantial psychological and financial burden on societies worldwide. Therefore, there is a clear need for therapeutic strategies or treatments for this disease. The aim of this study was to investigate the effects of a novel non-pharmacological approach for the treatment of Alzheimer’s disease based on the T-Consciousness Fields introduced by Mohammad Ali Taheri. This approach is proposed to act at the cellular and molecular levels. In this study, the effects of the Faradarmani Consciousness Field were evaluated in both an Alzheimer's disease mouse model (in vivo) and human neuronal cells (in vitro). For this purpose, human neuronal cell cultures and a traumatic brain injury (TBI) mouse model were used. Changes in amyloidopathy, tau protein content, microtubule aggregation, neuronal cell viability, and, finally, the behavior of TBI mice in the Elevated Plus Maze were assessed following Faradarmani treatment. According to the results obtained, treatment of human neuronal cells and the Alzheimer's disease mouse model with Faradarmani resulted in near-complete neuronal cell survival, elimination of amyloidopathy and tau protein accumulation, and significant behavioral improvement in TBI mice in the Elevated Plus Maze. Based on these findings, treatment with the Faradarmani Consciousness Field suppressed the progression of Alzheimer's disease in experimental models. Therefore, a human clinical study is proposed with the aim of introducing a new complementary medicine approach for the treatment of Alzheimer's disease.